Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Underperform on AbbVie, Lowers Price Target to $135

SVB Leerink analyst David Risinger maintains AbbVie (NYSE:ABBV) with a Underperform and lowers the price target from $140 to $135.
byBenzinga Newsdesk
September 30, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst David Risinger maintains AbbVie (NYSE:ABBV) with a Underperform and lowers the price target from $140 to $135.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts